• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Single-Cell Profiling Reveals Clonal Evolution in CML-to-BLBC Disease Progression

by
November 18, 2026
in Health
Reading Time: 3 mins read
0
Single-Cell Profiling Reveals Clonal Evolution in CML-to-BLBC Disease Progression

Single-Cell Profiling Reveals Clonal Evolution in CML-to-BLBC Disease Progression

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A longitudinal study involving paired single-cell transcriptomic profiling has identified critical cellular mechanisms driving the transformation of chronic-phase chronic myeloid leukemia (CML-CP) into B-lymphoblastic blast crisis (BLBC). The research, published in Molecular Medicine, delineates the evolutionary trajectory of the disease, highlighting substantial remodeling of the hematopoietic landscape during progression. Blast transformation is associated with the selective expansion of lymphoid-primed BCR::ABL1-positive progenitor populations, a process characterized by specific molecular programs that distinguish the progression to BLBC.

To investigate the cellular states and lineage trajectories involved in this transition, researchers conducted single-cell RNA sequencing (scRNA-seq) on five bone marrow samples. This cohort included two longitudinally paired CML-CP and BLBC sample sets from individual patients, alongside one additional BLBC sample. The team performed integrative analyses by incorporating publicly available scRNA-seq datasets from two patients with de novo Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia (Ph+ B-ALL) to determine the unique cellular characteristics of BLBC. Further validation of key findings was conducted using an external microarray dataset, an in-house bulk RNA-seq dataset, quantitative real-time PCR (qRT‒PCR), and flow cytometry.

The findings indicate that the hematopoietic landscape undergoes significant reorganization during disease progression. In the chronic phase, the samples displayed heterogeneous hematopoietic outputs with both erythroid- and myeloid-biased lineages, which were associated with distinct transcriptional programs. In contrast, the BLBC samples exhibited a marked shift toward relatively quiescent, stem cell-like cellular states.

A central finding of the research is the activation of a distinct lymphoid-associated transcriptional program during blast transformation. This molecular signature is characterized by the increased expression of CD24, DNTT, and RAG1.

Comparative analyses of the scRNA-seq data revealed that CML-BLBC exhibits a transcriptional landscape distinct from that of de novo Ph+ B-ALL. Among the genes identified as consistently upregulated in CML-BLBC, CD24 emerged as a key factor specifically enriched within ProB and PreB populations. This progressive upregulation of CD24 during the evolution of the disease was independently confirmed across all validation platforms, including microarray analysis and clinical flow cytometry.

The study also evaluated the clinical implications of these findings, particularly concerning treatment efficacy. Elevated CD24 expression was found to be associated with an inferior response to imatinib in untreated CML patients.

The researchers conclude that their paired longitudinal single-cell atlas provides a clearer understanding of the evolutionary trajectory from CML-CP to BLBC. The selective expansion of lymphoid-primed BCR::ABL1-positive progenitors, driven by the coordinated upregulation of CD24, DNTT, and RAG1, appears to be a key molecular event in this process.

Subject of Research: Molecular mechanisms of blast transformation in chronic myeloid leukemia

Article Title: Paired longitudinal single-cell profiling reveals clonal evolution and lymphoid lineage restriction during progression from chronic-phase CML to B-lymphoblastic blast crisis

Article References: Yan, S., Huang, D., Wang, X., Xie, F., & Zhang, X. (2026). Paired longitudinal single-cell profiling reveals clonal evolution and lymphoid lineage restriction during progression from chronic-phase CML to B-lymphoblastic blast crisis. Molecular Medicine. https://doi.org/10.1186/s10020-026-01681-4

Image Credits: AI Generated

DOI: 10.1186/s10020-026-01681-4

Keywords: Chronic Myeloid Leukemia, CML, Blast Crisis, Single-cell RNA sequencing, Transcriptomics, Clonal evolution, CD24, Hematopoiesis, B-lymphoblastic blast crisis, Lineage restriction, BCR::ABL1, Imatinib resistance, Leukemia research, Molecular medicine, Cell states

News Source: Gavin Prescott. (November 18, 2026). Single-Cell Profiling Reveals Clonal Evolution in CML-to-BLBC Disease Progression. Scienmag.

Tags: B-lymphoblastic blast crisisBCR::ABL1Blast CrisisCD24cell statesChronic Myeloid Leukemiaclonal evolutionCMLhematopoiesisimatinib resistanceleukemia researchLineage restrictionmolecular medicinesingle-cell RNA sequencingTranscriptomics
Share12Tweet7Share2ShareShareShare1

Related Posts

Adolescent Wellbeing Scale Shows Cross-Language Invariance but Exploratory Item Differences

Adolescent Wellbeing Scale Shows Cross-Language Invariance but Exploratory Item Differences

November 18, 2026
Review Examines CETP Inhibitor Obicetrapib and p-Tau-217 Progression

Review Examines CETP Inhibitor Obicetrapib and p-Tau-217 Progression

November 18, 2026

Trial Finds Purified Cannabidiol Yields Limited Adaptive Benefits in Severe Autism

November 18, 2026

BMP2 Gene Variant Linked to Human Cranial Base Size in 3D Analysis

November 18, 2026

POPULAR NEWS

  • Elite Luge Athletes Experience Seasonal Shifts in Body Composition and Biomarkers

    Elite Luge Athletes Experience Seasonal Shifts in Body Composition and Biomarkers

    29 shares
    Share 12 Tweet 7
  • Olive Oil Supplementation Remodels Plasma Lipids and Metabolites in Aged Tauopathy Mice

    29 shares
    Share 12 Tweet 7
  • Mitophagy Inhibitor Ac220 Enhances Magnolol Antitumor Action in Ewing Sarcoma

    29 shares
    Share 12 Tweet 7
  • Systematic Review Finds Long-Term Data Scarce for Chronic Neuropathic Pain Treatments

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Lynch Syndrome Urinary Tract Cancer Screening Yields High False-Positive Rates

Adolescent Wellbeing Scale Shows Cross-Language Invariance but Exploratory Item Differences

Review Examines CETP Inhibitor Obicetrapib and p-Tau-217 Progression

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.